HCC

>

Latest News

Addressing the Unique HCC Treatment Landscape With Fostrox
Addressing the Unique HCC Treatment Landscape With Fostrox

September 12th 2023

During a webcast, experts discussed the current and future treatment landscape of hepatocellular carcinoma and the need to explore combinations with chemotherapy.

Fostrox Plus Lenvatinib Shows Encouraging Results in HCC
Fostrox Plus Lenvatinib Shows Encouraging Results in HCC

September 6th 2023

Analyses Show Subgroup-Dependent Benefits of Immunotherapy in HCC
Analyses Show Subgroup-Dependent Benefits of Immunotherapy in HCC

August 1st 2023

Rivoceranib/Camrelizumab is Effective in the First-Line for uHCC
Rivoceranib/Camrelizumab is Effective in the First-Line for uHCC

July 25th 2023

Comparing IMbrave150 and HIMALAYA Outcomes in Frontline HCC
Comparing IMbrave150 and HIMALAYA Outcomes in Frontline HCC

July 24th 2023

Video Series
Video Interviews

More News